Review Article · e0001
Modern approaches to pharmaceutical manufacturing optimization: integrating Lean, QbD, PAT and Pharma 4.0 into the pharmaceutical quality system
Kuzmina V.V., Kuzmina R.V., Kizatova M.Zh., Rakhimova N.A., Sharipova O.F. Modern approaches to pharmaceutical manufacturing optimization: integrating Lean, QbD, PAT and Pharma 4.0 into the pharmaceutical quality system. Pharmaceutical Sciences and Health Products. 2026;1(1):e0001.
Abstract
The aim of this narrative review was to compare current approaches to pharmaceutical manufacturing optimization and to define their roles within the pharmaceutical quality system. Relevant scientific publications and regulatory documents were reviewed in PubMed, Scopus and Web of Science and supplemented with regulatory documents from ICH, FDA, WHO, PIC/S and the European Commission; the last search was conducted on 28 September 2026. Peer-reviewed publications from 2015-2026 were prioritized, while earlier sources were retained when they represented foundational or regulatory documents. The approaches were compared by management object, lifecycle stage, data requirements, performance indicators and limitations. Lean primarily addresses process flow and waste, Six Sigma focuses on variability, QbD on product and process design, PAT and continued process verification on monitoring and maintenance of a state of control, and Pharma 4.0 on data and system integration. These approaches should not be interpreted as a mandatory linear sequence. Their combination depends on process knowledge, data quality, regulatory constraints and the digital maturity of the manufacturing site. A comparative analytical model is proposed to position the reviewed tools within the pharmaceutical quality system.
Keywords
Article history
- Published
Peer-review model: Double-blind external peer review · Version: Version of Record
Supplementary materials
No separate supplementary materials.